Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination

Abstract Aspirin is a potent lysine acetylation inducer, but its impact on lysine ubiquitination and ubiquitination-directed protein degradation is unclear. Herein, we develop the reversed-pulsed-SILAC strategy to systematically profile protein degradome in response to aspirin. By integrating degrad...

Full description

Saved in:
Bibliographic Details
Main Authors: Jing Gao, Yang Liu, Chenfang Si, Rui Guo, Shouqiao Hou, Xiaosong Liu, Houfang Long, Di Liu, Daichao Xu, Zai-Rong Zhang, Cong Liu, Bing Shan, Christoph W. Turck, Kaiwen He, Yaoyang Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Nature Communications
Online Access:https://doi.org/10.1038/s41467-025-56737-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861791541690368
author Jing Gao
Yang Liu
Chenfang Si
Rui Guo
Shouqiao Hou
Xiaosong Liu
Houfang Long
Di Liu
Daichao Xu
Zai-Rong Zhang
Cong Liu
Bing Shan
Christoph W. Turck
Kaiwen He
Yaoyang Zhang
author_facet Jing Gao
Yang Liu
Chenfang Si
Rui Guo
Shouqiao Hou
Xiaosong Liu
Houfang Long
Di Liu
Daichao Xu
Zai-Rong Zhang
Cong Liu
Bing Shan
Christoph W. Turck
Kaiwen He
Yaoyang Zhang
author_sort Jing Gao
collection DOAJ
description Abstract Aspirin is a potent lysine acetylation inducer, but its impact on lysine ubiquitination and ubiquitination-directed protein degradation is unclear. Herein, we develop the reversed-pulsed-SILAC strategy to systematically profile protein degradome in response to aspirin. By integrating degradome, acetylome, and ubiquitinome analyses, we show that aspirin impairs proteasome activity to inhibit proteasomal degradation, rather than directly suppressing lysine ubiquitination. Interestingly, aspirin increases lysosomal degradation-implicated K63-linked ubiquitination. Accordingly, using the major pathological protein of Parkinson’s disease (PD), α-synuclein (α-syn), as an example of protein aggregates, we find that aspirin is able to reduce α-syn in cultured cells, neurons, and PD model mice with rescued locomotor ability. We further reveal that the α-syn aggregate clearance induced by aspirin is K63-ubiquitination dependent in both cells and PD mice. These findings suggest two complementary mechanisms by which aspirin regulates the degradation of soluble and insoluble proteins, providing insights into its diverse pharmacological effects that can aid in future drug development efforts.
format Article
id doaj-art-2ef8077f05864986a86dd1919afa5d1e
institution Kabale University
issn 2041-1723
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Nature Communications
spelling doaj-art-2ef8077f05864986a86dd1919afa5d1e2025-02-09T12:45:44ZengNature PortfolioNature Communications2041-17232025-02-0116111710.1038/s41467-025-56737-6Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitinationJing Gao0Yang Liu1Chenfang Si2Rui Guo3Shouqiao Hou4Xiaosong Liu5Houfang Long6Di Liu7Daichao Xu8Zai-Rong Zhang9Cong Liu10Bing Shan11Christoph W. Turck12Kaiwen He13Yaoyang Zhang14Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Chinese Academy of SciencesInterdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Haike Rd.Abstract Aspirin is a potent lysine acetylation inducer, but its impact on lysine ubiquitination and ubiquitination-directed protein degradation is unclear. Herein, we develop the reversed-pulsed-SILAC strategy to systematically profile protein degradome in response to aspirin. By integrating degradome, acetylome, and ubiquitinome analyses, we show that aspirin impairs proteasome activity to inhibit proteasomal degradation, rather than directly suppressing lysine ubiquitination. Interestingly, aspirin increases lysosomal degradation-implicated K63-linked ubiquitination. Accordingly, using the major pathological protein of Parkinson’s disease (PD), α-synuclein (α-syn), as an example of protein aggregates, we find that aspirin is able to reduce α-syn in cultured cells, neurons, and PD model mice with rescued locomotor ability. We further reveal that the α-syn aggregate clearance induced by aspirin is K63-ubiquitination dependent in both cells and PD mice. These findings suggest two complementary mechanisms by which aspirin regulates the degradation of soluble and insoluble proteins, providing insights into its diverse pharmacological effects that can aid in future drug development efforts.https://doi.org/10.1038/s41467-025-56737-6
spellingShingle Jing Gao
Yang Liu
Chenfang Si
Rui Guo
Shouqiao Hou
Xiaosong Liu
Houfang Long
Di Liu
Daichao Xu
Zai-Rong Zhang
Cong Liu
Bing Shan
Christoph W. Turck
Kaiwen He
Yaoyang Zhang
Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
Nature Communications
title Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
title_full Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
title_fullStr Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
title_full_unstemmed Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
title_short Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
title_sort aspirin inhibits proteasomal degradation and promotes α synuclein aggregate clearance through k63 ubiquitination
url https://doi.org/10.1038/s41467-025-56737-6
work_keys_str_mv AT jinggao aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT yangliu aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT chenfangsi aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT ruiguo aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT shouqiaohou aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT xiaosongliu aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT houfanglong aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT diliu aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT daichaoxu aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT zairongzhang aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT congliu aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT bingshan aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT christophwturck aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT kaiwenhe aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination
AT yaoyangzhang aspirininhibitsproteasomaldegradationandpromotesasynucleinaggregateclearancethroughk63ubiquitination